-
Gilead Stock Whiffs, But One Pro Remains Bullish
Wednesday, October 28, 2015 - 2:26pm | 432Read More...Shares of Gilead Sciences, Inc. (NASDAQ: GILD) were trading lower by more than 3 percent Wednesday afternoon. The company reported an upbeat third-quarter print, while full year guidance may have disappointed some investors. Wendy Lam of Oppenheimer maintained an Outperform rating and $...
-
Bristol-Myers' Trash is Gilead Sciences' Treasure
Friday, August 24, 2012 - 9:16am | 584Read More...Amid a track record of continued success and secured patents, Gilead Sciences (NASDAQ: GILD) is once again headlining the infectious disease realm with a new hepatitis C offering despite news that Bristol-Myers Squibb (NYSE: BMY) has discontinued its experimental therapy trials following a patient...
